These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30815763)

  • 1. Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy.
    Polesel J; Lupato V; Collarile P; Vaccher E; Fanetti G; Giacomarra V; Palazzari E; Furlan C; Matrone F; Navarria F; Gobitti C; Minatel E; Serraino D; Birri S; Franchin G
    Med Oncol; 2019 Feb; 36(4):31. PubMed ID: 30815763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy.
    Polesel J; Furlan C; Birri S; Giacomarra V; Vaccher E; Grando G; Gobitti C; Navarria F; Schioppa O; Minatel E; Bidoli E; Barzan L; Franchin G
    Oral Oncol; 2017 Apr; 67():175-182. PubMed ID: 28351574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Characteristics and Costs in Recurrent or Refractory Head and Neck Cancer: Retrospective Analysis of a Community Oncology Database.
    Fisher MD; Fernandes AW; Olufade TO; Miller PJ; Walker MS; Fenton M
    Clin Ther; 2018 Apr; 40(4):562-573. PubMed ID: 29530457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank.
    Verdonck-de Leeuw IM; Jansen F; Brakenhoff RH; Langendijk JA; Takes R; Terhaard CHJ; Baatenburg de Jong RJ; Smit JH; Leemans CR
    BMC Cancer; 2019 Aug; 19(1):765. PubMed ID: 31382921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of insurance type with time course of care in head and neck cancer management.
    Itamura K; Kokot N; Sinha U; Swanson M
    Laryngoscope; 2020 Nov; 130(11):E587-E592. PubMed ID: 31756005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation.
    Meregaglia M; Cairns J; Licitra L; Bossi P
    Eur J Cancer; 2018 Apr; 93():89-98. PubMed ID: 29477796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding financial toxicity in head and neck cancer survivors.
    Mady LJ; Lyu L; Owoc MS; Peddada SD; Thomas TH; Sabik LM; Johnson JT; Nilsen ML
    Oral Oncol; 2019 Aug; 95():187-193. PubMed ID: 31345389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Reduced Waiting Time for Head and Neck Cancer Patients due to a Lean Process Redesign.
    Simons PA; Ramaekers B; Hoebers F; Kross KW; Marneffe W; Pijls-Johannesma M; Vandijck D
    Value Health; 2015 Jul; 18(5):587-96. PubMed ID: 26297086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care population.
    Amonkar MM; Chastek B; Samant N; Teitelbaum A
    J Med Econ; 2011; 14(4):421-32. PubMed ID: 21619455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why are head and neck squamous cell carcinoma diagnosed so late? Influence of health care disparities and socio-economic factors.
    Adrien J; Bertolus C; Gambotti L; Mallet A; Baujat B
    Oral Oncol; 2014 Feb; 50(2):90-7. PubMed ID: 24268629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment.
    Carmignani I; Locatello LG; Desideri I; Bonomo P; Olmetto E; Livi L; Le Saec O; Coscarelli S; Mannelli G
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2159-2167. PubMed ID: 29978259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological and economic burden of potentially HPV-related cancers in France.
    Abramowitz L; Lacau Saint Guily J; Moyal-Barracco M; Bergeron C; Borne H; Dahlab A; Bresse X; Uhart M; Cancalon C; Catella L; Bénard S
    PLoS One; 2018; 13(9):e0202564. PubMed ID: 30235216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of care in a matched pair comparison of intensity-modulated radiation therapy (IMRT) versus conventional radiation therapy (CRT) for the treatment of head and neck cancer.
    Sheets NC; Wheeler SB; Kohler RE; Fried DV; Brown PM; Chera BS
    Am J Clin Oncol; 2014 Dec; 37(6):539-44. PubMed ID: 23466583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern methods to predict costs for the treatment and management of head and neck cancer patients: examples of methods used in the current literature.
    Wineland AM; Stack BC
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):113-6. PubMed ID: 18327029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hospital safety-net burden status on short-term outcomes and cost of care after head and neck cancer surgery.
    Genther DJ; Gourin CG
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1015-22. PubMed ID: 23165375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curative treatment of head and neck squamous cell carcinoma : Organ preservation strategies in clinical routine in German-speaking countries.
    Kurzweg T; Kimmeyer J; Knecht R; Hoffmann TK; Busch CJ; Lörincz BB; Schuler PJ; Laban S
    HNO; 2016 Jul; 64(7):501-7. PubMed ID: 27357174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of patients who decline treatment for squamous cell carcinoma of the head and neck: National perspective.
    Sullivan CB; Al-Qurayshi Z; Pagedar NA
    Head Neck; 2020 Apr; 42(4):698-707. PubMed ID: 31895475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients.
    Kim Le T; Winfree KB; Yang H; Marynchenko M; Yu AP; Frois C; Wu EQ
    J Med Econ; 2012; 15(4):786-95. PubMed ID: 22475042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.